Viewing Study NCT06358664



Ignite Creation Date: 2024-05-06 @ 8:21 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06358664
Status: RECRUITING
Last Update Posted: 2024-04-12
First Post: 2024-04-04

Brief Title: Caffeine and Cataract After Pars Plana Vitrectomy
Sponsor: Vienna Institute for Research in Ocular Surgery
Organization: Vienna Institute for Research in Ocular Surgery

Study Overview

Official Title: The Effect of Caffeine Consumption on Cataract Formation After Pars Plana Vitrectomy a Comparative Study
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Assessment of cataract development in patients with regular caffeine consumption and those without caffeine consumption after pars plana vitrectomy
Detailed Description: Vitrectomy is a frequently used surgical procedure in ophthalmology for various indications like retinal detachment repair or macular pucker peeling Amongst others accelerated cataract development in phakic patients is a known complication after vitrectomy A previous study found that especially patients receiving gas tamponade are at increased risk for postoperative cataract development The assumed mechanism behind this finding is that vitrectomy leads to an increased partial pressure of O2 in the human vitreous - similar to that observed in posterior vitreous detachment - subsequently leading to accelerated lens opacification Therefore a possible target of cataract prevention is the inhibition of oxygen radical formation One known antioxidant agent inhibiting oxygen radical formation is caffeine For instance in-vitro studies showed that caffeine consumption can reduce cataract development in ultraviolet UV-radiation-exposed rats and human lens epithelial cells through its capability of inhibiting oxygen radical formation These in-vitro studies support the findings of epidemiological studies that caffeine also in-vivo has the potential to reduce cataractogenesis Conflating the previous findings of accelerated cataract formation after vitrectomy and the preventive properties of caffeine for cataract development there may be a benefit for patients regularly consuming caffeine-containing beverages like coffee undergoing vitrectomy regarding postoperative cataract formation

Therefore the aim of this comparative study is to investigate if patients undergoing small gauge pars plana vitrectomy regularly consuming caffeine have lower postoperative significant cataract formation rates than patients not consuming caffeine

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None